An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.
Trial HIV Vaccine Sparks Key Antibodies in Humans miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
A trial HIV vaccine triggered elusive and essential antibodies in humans sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.
A Trial HIV Vaccine Triggered Elusive and Essential Antibodies in Humans dukehealth.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dukehealth.org Daily Mail and Mail on Sunday newspapers.
Scientists, doctors and other health professionals from the HIV Vaccine Trials Network (HVTN) will present research findings and other HIV-related news at AIDS